| Cheryl Anne Wagner, ARNP | |
|
7600 E Florentine Rd, Prescott Valley, AZ 86314-1295 | |
| (928) 772-1610 | |
| Not Available |
| Full Name | Cheryl Anne Wagner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 7600 E Florentine Rd, Prescott Valley, Arizona |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023444049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 227591 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Behavioral Health Services Inc | 9739075854 | 23 |
News Archive
Respiratory diseases are one of the leading causes of death and suffering in the EU. The challenge Europe is facing in this field goes far beyond public health: lung diseases currently cause an annual cost of €100 billion and threaten the Europe 2020 strategy and the goal to have 75% of the working population employed and productive.
Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.
The Sensory Research Center (SRC) invites you to a Benefit Concert, Dessert and Auction, featuring LA Collaboration, at Journey of Faith Church in Manhattan Beach, 1243 Artesia Blvd, Manhattan Beach, CA - (310) 372-4641 at 7:00 PM. Mention this article and receive 2 for the price of 1 tickets.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
› Verified 9 days ago
| Entity Name | Southwest Behavioral Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144384389 PECOS PAC ID: 9739075854 Enrollment ID: O20040225000948 |
News Archive
Respiratory diseases are one of the leading causes of death and suffering in the EU. The challenge Europe is facing in this field goes far beyond public health: lung diseases currently cause an annual cost of €100 billion and threaten the Europe 2020 strategy and the goal to have 75% of the working population employed and productive.
Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.
The Sensory Research Center (SRC) invites you to a Benefit Concert, Dessert and Auction, featuring LA Collaboration, at Journey of Faith Church in Manhattan Beach, 1243 Artesia Blvd, Manhattan Beach, CA - (310) 372-4641 at 7:00 PM. Mention this article and receive 2 for the price of 1 tickets.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl Anne Wagner, ARNP 3450 N 3rd St, Phoenix, AZ 85012-2331 Ph: (602) 351-6986 | Cheryl Anne Wagner, ARNP 7600 E Florentine Rd, Prescott Valley, AZ 86314-1295 Ph: (928) 772-1610 |
News Archive
Respiratory diseases are one of the leading causes of death and suffering in the EU. The challenge Europe is facing in this field goes far beyond public health: lung diseases currently cause an annual cost of €100 billion and threaten the Europe 2020 strategy and the goal to have 75% of the working population employed and productive.
Four Washington-based teams of investigators will receive up to $150,000 each to support commercial development of new health and health-care products, the Life Sciences Discovery Fund announced today.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.
The Sensory Research Center (SRC) invites you to a Benefit Concert, Dessert and Auction, featuring LA Collaboration, at Journey of Faith Church in Manhattan Beach, 1243 Artesia Blvd, Manhattan Beach, CA - (310) 372-4641 at 7:00 PM. Mention this article and receive 2 for the price of 1 tickets.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
› Verified 9 days ago
Mrs. Holly Ann Allred, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6386 E Ashton Pl, Prescott Valley, AZ 86314 Phone: 928-533-3971 | |
Reneallia Bennett, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3075 N Windsong Dr Ste A, Prescott Valley, AZ 86314 Phone: 928-350-8780 Fax: 888-674-1228 | |
Laura Finkbeiner, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 101, Prescott Valley, AZ 86314 Phone: 605-685-3995 | |
Kelly L Marshall, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 101, Prescott Valley, AZ 86314 Phone: 928-442-8710 Fax: 928-442-8742 | |
Lindsey M Robbins, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3251 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-772-2582 | |
Amy M Thein, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3345 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-445-5211 |